Biology of transforming growth factor β in Uhepatocarcinogenesis

Microscopy Research and Technique

Volumn 52, Issue 4, 2001, Pages 430-436

  Rossmanith, Walter ^a,b   Schulte Hermann, Rolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hepatocellular carcinoma; Liver; TGF ; TGF signaling

Indexed keywords

DISEASES; MAMMALS; TUMORS;

HEPATOCELLULAR CARCINOMA; HEPATOCYTE DNA SYNTHESIS; OVEREXPRESSIONS; TGF-Β; TGF-Β SIGNALING; TISSUE MASS; TRANSFORMING GROWTH FACTORS; TRANSGENIC MICE; WELL BALANCED; HEPATOCARCINOGENESIS; SIGNALING;

CELL DEATH;

DNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CELL DEATH; DNA SYNTHESIS INHIBITION; GENE MUTATION; HUMAN; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR ESCAPE; TUMOR VASCULARIZATION;

MUS MUSCULUS;

EID: 0035865440     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO;2-3     Document Type: Review

References (83)

1. Transforming growth factor-β1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers
2. The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice
3. Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation
4. Transforming growth factor β1 in liver carcinogenesis: Messenger RNA expression and growth effects
5. Inhibition of transforming growth factor β1-induced hepatoma cell apoptosis by liver tumor promoters: Characterization of primary signaling events and effects on CPP32-1ike caspase activity
6. Transforming growth factor-β1 as a signal for induction of cell death by apoptosis
7. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor
8. Involvement of caspase family proteases in transforming growth factor-β-induced apoptosis
9. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens
10. Characterization of apoptosis induced by transforming growth factor β1 in human hepatoma cells
11. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
12. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
13. Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice
14. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
15. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice
16. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells
17. Liver regeneration
18. Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma
19. Transforming growth factor beta (TGF-β) expression in isolated and cultured rat hepatocytes
20. Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression
21. Levels of transforming growth factor β and transforming growth factor β receptors in rat liver during growth, regression by apoptosis and neoplasia
22. 4, a candidate tumor suppressor gene at human chromosome 18q21.1
23. B is a potential effector of TGF-β-induced cell cycle arrest
24. Processing/activation of CPP32-like proteases is involved in transforming growth factor β1-induced apoptosis in rat hepatocytes
25. Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma
26. Mitochondrial membrane permeabilization during the apoptotic process
27. Transforming growth factor-β (TGF-β) isoforms in rat liver regeneration: Messenger RNA expression and activation of latent TGF-β
28. Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration
29. Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital
30. Mutation analysis of transforming growth factor β type II receptor, Smad2, and Smad4 in hepatocellular carcinoma
31. Analysis of transforming growth factor (TGF)-α/epidermal growth factor receptor, hepatocyte growth factor/c-met, TGF-β receptor type II, and p53 expression in human hepatocellular carcinomas
32. The role of activin and transforming growth factor-β in the regulation of organ mass in the rat liver
33. Selective loss of the transforming growth factor-β apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells
34. Regulation of immune responses by TGF-β
35. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1
36. Phenobarbital selectively promotes initiated cells with reduced TGFβ receptor levels
37. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
38. Controlling TGF-β signaling
39. Liver regeneration
40. Transforming growth factorβ1-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen
41. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture
42. Expression of transforming growth factor-β1 during chemical hepatocarcinogenesis in the rat
43. Role for Bcl-xL in the regulation of apoptosis by EGF and TGF β1 in c-myc overexpressing mammary epithelial cells
44. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: Increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition
45. Effect of transforming growth factor β on cell death of cultured rat hepatocytes
46. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1
47. Apoptosis is induced by transforming growth factor-β1 within 5 hours in regressing liver without significant fragmentation of the DNA
48. The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation
49. Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: A role for transforming growth factor beta
50. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer
51. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
52. Follistatin: A multifunctional regulatory protein
53. Transforming growth factor-β receptors type I, II and III in phenobarbital-promoted rat liver tumors
54. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β
55. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation
56. Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-α and transforming growth factor-β mRNA production
57. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat
58. Microsatellite instability in European hepatocellular carcinoma
59. Apoptosis induced by transforming growth factor-β in fetal hepatocyte primary cultures: Involvement of reactive oxygen intermediates
60. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions
61. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α
62. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α
63. Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-α in transgenic mice is associated with TGF-β1 signaling disruption
64. Chemical hepatocarcinogenesis in transgenic mice overexpressing mature TGF β-1 in liver
65. Apoptosis and hepatocarcinogenesis
66. Activin induces cell death in hepatocytes in vivo and in vitro
67. Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases
68. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
69. Serial killers: Ordering caspase activation events in apoptosis
70. Transforming growth factor β inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver
71. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma
72. Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor β1
73. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
74. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers
75. Elevated urinary transforming growth factor-β1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma
76. Mutation analysis of the transforming growth factor β type II receptor in sporadic human cancers of the pancreas, liver, and breast
77. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan
78. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-β
79. Transforming growth factor-β signaling and cirrhosis
80. Smad2 and Smad4 gene mutations in hepatocellular carcinoma
81. Inhibition by dexamethasone of transforming growth factor β1-induced apoptosis in rat hepatoma cells: A possible association with Bcl-xL induction
82. Activin A: An autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes
83. Liver cell dysplasia: Reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-β1 in comparison with hepatocellular carcinoma